{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:51:39Z","timestamp":1780048299053,"version":"3.53.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bbr.2021.113167","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T15:17:04Z","timestamp":1612883824000},"page":"113167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice"],"prefix":"10.1016","volume":"405","author":[{"given":"Zackary A.","family":"Cope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny A.","family":"Kenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen V.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Arnt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordy","family":"van Enkhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10027","key":"10.1016\/j.bbr.2021.113167_bib0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 8","key":"10.1016\/j.bbr.2021.113167_bib0010","first-page":"35","article-title":"Decision tree for the treatment of bipolar disorder","volume":"64","author":"Sachs","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40345-019-0145-0","article-title":"Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy","volume":"7","author":"Jauhar","year":"2019","journal-title":"Int. J. Bipolar Disord."},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.bbr.2021.113167_bib0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/0019-5545.58304","article-title":"The story of antipsychotics: past and present","volume":"51","author":"Ramachandraiah","year":"2009","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113167_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(97)00023-1","article-title":"Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels","volume":"75","author":"Knable","year":"1997","journal-title":"Psychiatry Res.: Neuroimag. Sect."},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0976-500X.64538","article-title":"Asenapine, a new sublingual atypical antipsychotic","volume":"1","author":"Balaraman","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"101","key":"10.1016\/j.bbr.2021.113167_bib0040","first-page":"1","article-title":"Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes_a post hoc analysis of two 3-week clinical trials","volume":"11","author":"Szegedi","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J. Psychopharmacol. (Oxford Engl.)"},{"issue":"5","key":"10.1016\/j.bbr.2021.113167_bib0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2021.113167_bib0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","article-title":"Striatal dopamine transporter availability in unmedicated bipolar disorder","volume":"13","author":"Anand","year":"2011","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.bbr.2021.113167_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.mp.4001764","article-title":"Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples","volume":"11","author":"Greenwood","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbr.2021.113167_bib0065","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.mp.4001730","article-title":"A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression","volume":"10","author":"Horschitz","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbr.2021.113167_bib0070","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41386-018-0031-y","article-title":"Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder","volume":"43","author":"Young","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.bbr.2021.113167_bib0075","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/npp.2011.45","article-title":"Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder","volume":"36","author":"Pinsonneault","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2021.113167_bib0080","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0269881111400646","article-title":"Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania","volume":"25","author":"Young","year":"2011","journal-title":"J. Psychopharmacol. (Oxford Engl.)"},{"issue":"4","key":"10.1016\/j.bbr.2021.113167_bib0085","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","article-title":"Hyperactivity and impaired response habituation in hyperdopaminergic mice","volume":"98","author":"Zhuang","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.bbr.2021.113167_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2017.12.007","article-title":"Dopamine transporter knockdown mice in the behavioral pattern monitor: a robust, reproducible model for mania-relevant behaviors","volume":"178","author":"Kwiatkowski","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"10","key":"10.1016\/j.bbr.2021.113167_bib0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","article-title":"A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men","volume":"66","author":"Perry","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbr.2021.113167_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024185","article-title":"Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals","volume":"6","author":"Minassian","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbr.2021.113167_bib0105","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2021.113167_bib0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0091-3057(02)00727-X","article-title":"Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats","volume":"72","author":"Rosengarten","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bbr.2021.113167_bib0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2011.06.011","article-title":"Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801","volume":"500","author":"Roenker","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pnpbp.2012.06.013","article-title":"Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain","volume":"39","author":"Stojkovic","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00213-009-1712-3","article-title":"Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice","volume":"208","author":"Delotterie","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.bbr.2021.113167_bib0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/FBP.0000000000000128","article-title":"The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors","volume":"26","author":"Ene","year":"2015","journal-title":"Behav. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbr.2021.113167_bib0135","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/sj.npp.1301161","article-title":"Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice","volume":"31","author":"Risbrough","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.bbr.2021.113167_bib0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ccr3.526","article-title":"Asenapine augmentation in bipolar disorders: a case series","volume":"4","author":"Marazziti","year":"2016","journal-title":"Clin. Case Rep."},{"issue":"5","key":"10.1016\/j.bbr.2021.113167_bib0145","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0091270011404028","article-title":"Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations","volume":"52","author":"Gerrits","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113167_bib0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/nedt.2006.2.2.127","article-title":"Risperidone in the treatment of bipolar mania","volume":"2","author":"Sajatovic","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.bbr.2021.113167_bib0155","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/106002809502900611","article-title":"Risperidone: review and assessment of its role in the treatment of schizophrenia","volume":"29","author":"Cardoni","year":"1995","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.bbr.2021.113167_bib0160","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00213-017-4543-7","article-title":"Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania","volume":"234","author":"Milienne-Petiot","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"issue":"18","key":"10.1016\/j.bbr.2021.113167_bib0165","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s00213-015-4000-4","article-title":"Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features","volume":"232","author":"van Enkhuizen","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2021.113167_bib0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00213-003-1553-4","article-title":"Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains","volume":"171","author":"Zarate","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2021.113167_bib0175","article-title":"A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter","author":"Amato","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113167_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2020.11.004","article-title":"Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice","volume":"42","author":"Kwiatkowski","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113167_bib0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s002130000532","article-title":"Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study","volume":"152","author":"Silvestri","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.bbr.2021.113167_bib0190","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu068","article-title":"Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat","volume":"18","author":"Bjorkholm","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2021.113167_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/17460441.2013.738193","article-title":"The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar disorder","volume":"8","author":"Tarazi","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bbr.2021.113167_bib0200","first-page":"1145","article-title":"Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder","volume":"9","author":"Gao","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"20","key":"10.1016\/j.bbr.2021.113167_bib0205","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.12710","article-title":"Sex differences in animal models of psychiatric disorders","volume":"171","author":"Kokras","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2021.113167_bib0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/09540261.2010.514601","article-title":"Is sex important? Gender differences in bipolar disorder","volume":"22","author":"Diflorio","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","article-title":"The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration","volume":"96","author":"Young","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113167_bib0220","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2017.07.020","article-title":"Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1","volume":"125","author":"Green","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113167_bib0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neuropharm.2016.03.047","article-title":"The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms","volume":"107","author":"Landgraf","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113167_bib0230","first-page":"1","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","author":"van Enkhuizen","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2021.113167_bib0235","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.001753","article-title":"Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes","author":"Herborg","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbr.2021.113167_bib0240","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","article-title":"Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride","volume":"24","author":"Pruessner","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2021.113167_bib0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/070674371305800109","article-title":"Childhood trauma as a cause of psychosis: linking genes, psychology, and biology","volume":"58","author":"van Winkel","year":"2013","journal-title":"Can. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2021.113167_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jad.2009.08.005","article-title":"The impact of comorbid posttraumatic stress disorder on bipolar disorder patients","volume":"123","author":"Quarantini","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2021.113167_bib0255","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2016.00148","article-title":"Trace amines and the trace amine-associated receptor 1: pharmacology, neurochemistry, and clinical implications","volume":"10","author":"Pei","year":"2016","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2021.113167_bib0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/a-0590-4992","article-title":"Genetics of Lithium response in bipolar disorder","volume":"51","author":"Papiol","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"10023","key":"10.1016\/j.bbr.2021.113167_bib0265","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bbr.2021.113167_bib0270","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2217\/pgs.10.127","article-title":"Pharmacogenetics of lithium response in bipolar disorder","volume":"11","author":"McCarthy","year":"2010","journal-title":"Pharmacogenomics"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:26:03Z","timestamp":1759065963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432821000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":54,"alternative-id":["S0166432821000541"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113167","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113167"}}